Impaired facial emotion recognition in relation to social behaviours in de novo Parkinson's disease.

Autor: Slomp, Anne Carien, van der Zee, Sygrid, Boertien, Jeffrey M., Gerritsen, Marleen J. J., van Laar, Teus, Spikman, Jacoba M., Verwey, N. A., Van Harten, B., Portman, A. T., Langedijk, M. J. H., Oomes, P. G., Jansen, B. J. A. M., Van Wieren, T., Van den Bogaard, S. J. A., Van Steenbergen, W., Duyff, R., Van Amerongen, J. P., Fransen, P. S. S., Polman, S. K. L., Zwartbol, R. T.

Publikováno v: Journal of Neuropsychology; Jun2024, Vol. 18 Issue 2, p205-216, 12p

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.

Autor: Boertien, Jeffrey M., van der Zee, Sygrid, Chrysou, Asterios, Gerritsen, Marleen J. J., Jansonius, Nomdo M., Spikman, Jacoba M., van Laar, Teus, the PPNN Study Group, Verwey, N. A., Van Harten, B., Portman, A. T., Langedijk, M. J. H., Oomes, P. G., Jansen, B. J. A. M., Van Wieren, T., Van den Bogaard, S. J. A., Van Steenbergen, W., Duyff, R., Van Amerongen, J. P., Fransen, P. S. S.

Publikováno v: BMC Neurology; 6/13/2020, Vol. 20 Issue 1, p1-11, 11p, 1 Diagram, 2 Charts

Exploring barriers to college student use of disability services and accommodations

Autor: Marshak, L., Van Wieren, T., Ferrell, D. R., Swiss, L., & Dugan, C.

Learning difficulties, emotional issues, and modest intellectual disabilities are all prevalent disabilities. There are typically more parallels than differences between their behavioral and academic traits.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cfdaf5658ca2232f3c49b3627355c5c

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology

Autor: Boertien, Jeffrey M., van der Zee, Sygrid, Chrysou, Asterios, Gerritsen, Marleen J. J., Jansonius, Nomdo M., Spikman, Jacoba M., van Laar, Teus, Verwey, N. A., van Harten, B., Portman, A. T., Langedijk, M. J. H., Oomes, P. G., Jansen, B. J. A. M., van Wieren, T., van den Bogaard, S. J. A., van Steenbergen, W., Duyff, R., van Amerongen, J. P., Fransen, P. S. S., Polman, S. K. L., Zwartbol, R. T., van Kesteren, M. E., Braakhekke, J. P., Trip, J., Koops, L., de Langen, C. J., de Jong, G., Hartono, J. E. S., Ybema, H., Bartels, A. L., Reesink, F. E., Postma, A. G., Vonk, G. J. H., Oen, J. M. T. H., Brinkman, M. J., Mondria, T., Holscher, R. S., van der Meulen, A. A. E., Rutgers, A. W. F., Boekestein, W. A., Teune, L. K., Orsel, P. J. L., Hoogendijk, J. E., van Laar, T.

Publikováno v: BMC neurology, 20(1):245. BioMed Central
BMC Neurology, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Neurology
BMC NEUROLOGY, 20(1):245. BioMed Central Ltd.

Background Parkinson’s Disease (PD) is a heterogeneous, progressive neurodegenerative disorder which is characterized by a variety of motor and non-motor symptoms. To date, no disease modifying treatment for PD exists. Here, the study protocol of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792e0d2a63c6874cd0f04d3cc1a57af0